tweetindex
ID

Dr. John Cush ✓

@RheumNow · Dallas, TX · joined 08 Apr 2011

Know-it-Now. Info on RA, Stills disease, Lupus, Gout, Pregnancy, Spondylitis, Psoriasis, Drug Safety, Rheumatology Research, Medical Education & Drug Evaluation

25 703Followers
450Following
35 442Posts total
2.9KViews on collected posts

Postingan terbaru

Join us for Tuesday Nite Rheumatology on September 22 for: Obesity Treatment & Safety Experts will tackle: • GLP-1/GIP therapies • Lifestyle & bariatric interventions • Treatment selection & safety • Cost & compounding concerns • Sarcopenia & bone health • The future of https://t
290 views · 2 likes · 2 reposts · 0 replies Open on X →
🚨NEW FROM EULAR: In biologic-naive PsA, how do IL-23i, TNFi, and IL-17i compare on joint outcomes? 🦴Real-world data on TJC/SJC now available. Sponsored by AbbVie Medical Affairs + Health Impact. https://t.co/MG730IkB2w https://t.co/IAz2UaD2Eg
359 views · 1 likes · 0 reposts · 0 replies Open on X →
Review of HLA-B27 What’s New? HLA-B27 remains the dominant genetic link to spondyloarthritis (SpA) across the age spectrum, but B27 related clinical expression diverges between children and adults. New mechanistic data on autoreactive T cells, HLA-B27 misfolding, and gut-joint
698 views · 18 likes · 8 reposts · 0 replies Open on X →
Added IVIG is Effective in Myositis A small randomized controlled trial demonstrates that intravenous immunoglobulin (IVIG) added to cortocosteroids lead to greater and faster improvements in patients with newly diagnosed idiopathic inflammatory myopathies (IIMs). https://t.co/
623 views · 9 likes · 4 reposts · 0 replies Open on X →
Obesity & Inflammation https://t.co/zmZe9YJFvx 880 views · 6 likes · 2 reposts · 0 replies Open on X →

Dibandingkan akun berukuran sama

5 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. menjangkau lebih sedikit orang dibanding akun seukurannya.

Median tayangan623akun ini1 020median untuk 10K–100K
Jangkauan, %2.42%akun ini4.00%median untuk 10K–100K
Interaksi, %1.38%akun ini1.55%median untuk 10K–100K
MetrikAkun iniMedian untuk 10K–100KRasio
Median tayangan per postingan6231 0200.61×
Jangkauan (tayangan ÷ pengikut)2.42%4.00%0.61×
Tingkat interaksi1.38%1.55%0.89×

Akun lain pada rentang ini →   Bandingkan dengan akun lain →   Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

88015 Sep
62318 Sep
698
359
29019 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.02%15 Sep
2.09%18 Sep
3.87%
0.28%
1.38%19 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.55%.

What the audience does

Likes53.7%36 in total
Reposts23.9%16 in total
Quotes3.0%2 in total
Bookmarks19.4%13 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Akun serupa